All Conditions
Condition Guide

Polycystic Kidney Disease (PKD)

PKD is the most common inherited kidney disease, causing fluid-filled cysts that gradually replace kidney tissue. Blood tests and imaging track its progression.1

Written by Suman Konda, Clinical Pharmacist · Based on peer-reviewed sources · Editorial policy · Not medical advice

Last reviewed and updated: · How we check our content

What polycystic kidney disease is

Advertisement

Polycystic kidney disease (PKD) is the most common inherited kidney disease: numerous fluid-filled cysts grow progressively within both kidneys, gradually replacing normal tissue. In autosomal dominant PKD (ADPKD), affecting roughly 1 in 400–1000 people, a single inherited mutation in the PKD1 or PKD2 gene disrupts normal tubular cell signalling, driving cyst growth that compresses surrounding tissue, distorts blood supply and triggers inflammation and fibrosis.

Unlike most kidney diseases, PKD typically does not cause kidney failure until middle age — average onset of end-stage renal disease is 54 years for PKD1 mutations and 74 for PKD2. Total kidney volume on MRI is the best predictor of progression rate.13

PKD: myths vs facts

PKD is widely misunderstood. Here is what the evidence says:

MYTH PKD is the same as simple kidney cysts.

FACT Simple cysts are common and harmless with age. PKD is different: bilateral, progressive and inherited — confusing the two delays proper monitoring.

MYTH Everyone with PKD ends up on dialysis.

FACT Many maintain adequate kidney function for decades. Progression varies — which is exactly why monitoring matters rather than assuming the worst.

MYTH A blood test can diagnose PKD.

FACT ADPKD is diagnosed by renal ultrasound, with cyst-number thresholds that vary by age (15–39, 40–59, 60 plus). There is no specific PKD blood test: monitoring tracks the consequences — eGFR, creatinine, urine ACR, blood pressure.

MYTH High blood pressure in PKD is just a coincidence.

FACT Hypertension affects around 70% of patients and is a major driver of progression. Well-controlled blood pressure helps slow the disease — it is part of treatment, not background noise.

MYTH Nothing can slow PKD down.

FACT Blood pressure control is the foundation, and tolvaptan — approved specifically for ADPKD — slows cyst growth and preserves kidney function in rapidly progressing patients, though it needs specialist selection and liver monitoring.2

What to do next

A PKD diagnosis sets up long-term monitoring rather than a one-off fix:

  1. Confirm the diagnosis by imaging criteria. Renal ultrasound with age-appropriate cyst thresholds; MRI gives the more accurate total kidney volume measurement that predicts progression.
  2. Establish the monitoring rhythm. Blood pressure, eGFR and creatinine, urine albumin-to-creatinine ratio — tracked regularly since decline is often insidiously gradual for decades.
  3. Treat blood pressure as disease treatment. Ask your nephrologist what target applies to you; hypertension control is one of the few levers proven to slow progression.
  4. Discuss family implications. With 50% inheritance per child, ask whether your children should be tested — and whether intracranial aneurysm screening (MRA) is advised if there is a family history of rupture.
  5. Ask about tolvaptan eligibility. For rapidly progressing ADPKD (Mayo Class 1C–1E or equivalent eGFR decline), your nephrologist can assess whether you are a candidate.

Practical notes

PKD is monitored over years, so the trend is the story. Blood pressure readings taken at home and logged with dates give a fuller picture than occasional clinic readings, since hypertension is common in PKD. Kidney function (eGFR and creatinine) typically changes gradually — keeping reports in chronological order lets your doctor spot the slope of change rather than reacting to a single value.

Helpful history for your nephrologist includes a detailed family history of kidney disease, dialysis or transplantation, your home blood-pressure log, a complete medicine list (kidney doctors are particularly interested in regular NSAID painkiller use), episodes of flank pain or visible blood in the urine with dates, and roughly how much fluid you drink daily.

The lifestyle measures most often discussed in PKD are keeping blood pressure well controlled (including moderating salt intake), staying well hydrated — some nephrologists advise generous water intake, though the right amount is individual — avoiding regular use of medicines that can harm the kidneys such as NSAIDs, not smoking, and maintaining a healthy weight. None of these stops cyst growth, but they support overall kidney health.

Follow-up usually means kidney function blood tests and urine tests every 6–12 months, blood pressure checks at each visit, and kidney imaging (ultrasound, or MRI for precise volume measurement) at intervals your nephrologist sets — often every one to two years. If disease-modifying treatment is ever considered, additional monitoring such as regular liver tests becomes part of the schedule.

In India

A kidney ultrasound typically costs ₹800–₹2,000, kidney function blood tests a few hundred rupees, and an MRI of the abdomen — used for precise kidney-volume measurement — typically ₹5,000–₹15,000, though prices vary widely by city and facility.

Look for NABL-accredited laboratories and imaging centres, which follow standardised quality processes. In major cities, most large labs offer home sample collection for the blood tests; imaging is done at a diagnostic centre. Whatever a lab's website says about normal values, the reference range printed on your own report is the one that counts, since ranges differ between machines and assay methods.

Frequently asked questions

Is polycystic kidney disease inherited?

Most cases are autosomal dominant, meaning a parent with the condition has a 50% chance of passing it to each child. A rarer recessive form appears in infancy. Genetic testing can identify PKD1 or PKD2 mutations — PKD2 progresses more slowly.

How is PKD monitored?

Regular blood pressure checks, kidney function tests (eGFR, creatinine) and imaging. Well-controlled blood pressure helps slow progression, which is why hypertension — affecting around 70% of patients — is treated as a priority, not a side issue.

Does everyone with PKD need dialysis?

No. Progression varies widely: many maintain adequate kidney function for decades, though some progress to kidney failure needing dialysis or transplant. End-stage renal disease arrives on average at 54 years for PKD1 and 74 for PKD2 mutations.

What is total kidney volume and why does it matter?

Total kidney volume (TKV), measured by MRI, is the best predictor of how fast PKD will progress. The Mayo imaging classification uses it to identify rapid progressors who may benefit from closer monitoring and disease-modifying treatment.3

What is tolvaptan?

Tolvaptan is a vasopressin V2 receptor antagonist approved specifically for ADPKD — the first disease-modifying treatment. Trials showed it slows the rate of eGFR decline by roughly 30% in rapidly progressing patients, but it causes significant diuresis and carries a risk of serious liver toxicity requiring regular liver function monitoring. Eligibility is a specialist decision.24

My father has PKD — at what age should I get screened?
There is no single recommended age, because cysts can appear at different times and ultrasound may miss very early disease in young adults. Many nephrologists suggest discussing screening in early adulthood if you have a first-degree relative with ADPKD, and genetic counselling is available for those who want it — your doctor can advise on timing for your situation.
Can I take painkillers for headaches if I have PKD?
Occasional use is a question for your own doctor, but nephrologists generally advise people with kidney disease to avoid regular NSAID painkillers, since these can reduce kidney function. Always mention your kidney condition when any doctor prescribes or recommends a painkiller.
Does drinking more water slow down PKD?
There is scientific interest in this: high water intake suppresses vasopressin, the same hormone pathway targeted by the PKD medicine tolvaptan. Some nephrologists do advise generous hydration, but ‘more is always better’ is not proven and overdoing it carries its own risks — ask your nephrologist what fluid intake suits your stage of disease.
If I have ADPKD, will each of my children inherit it?
Each child of a parent with ADPKD has a 50% chance of inheriting the gene variant, and a 50% chance of not — it is not certain either way, and severity can differ even within a family. A genetic counsellor or your nephrologist can explain what this means for family planning if you are thinking about it.

References

Sources cited on this page. PubMed links open the original abstract.

  1. Torres VE, Harris PC, Pirson Y. Autosomal dominant polycystic kidney disease. Lancet. 2007;369(9569):1287–1301. PMID 17434405 · doi:10.1016/S0140-6736(07)60601-1
  2. Torres VE, Chapman AB, Devuyst O, et al. Tolvaptan in Later-Stage Autosomal Dominant Polycystic Kidney Disease. N Engl J Med. 2017;377(20):1930–1942. PMID 29105594 · doi:10.1056/NEJMoa1710030
  3. Cornec-Le Gall E, Alam A, Perrone RD. Autosomal dominant polycystic kidney disease. Lancet. 2019;393(10174):919–935. PMID 30819518 · doi:10.1016/S0140-6736(18)32782-X
  4. Torres VE, Chapman AB, Devuyst O, et al. Tolvaptan in Patients with Autosomal Dominant Polycystic Kidney Disease. N Engl J Med. 2012;367(25):2407–2418. PMID 23121377 · doi:10.1056/NEJMoa1205511
Medical Disclaimer: For educational purposes only. Always consult a qualified healthcare professional for diagnosis and treatment.
Written and medically reviewed by Suman Konda, Clinical Pharmacist · Sources linked to PubMed · Not medical advice: see our disclaimer